67
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain

, , , , &
Pages 327-336 | Published online: 05 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria P. Yavropoulou, Polyzois Makras & Athanasios D. Anastasilakis. (2019) Bazedoxifene for the treatment of osteoporosis. Expert Opinion on Pharmacotherapy 20:10, pages 1201-1210.
Read now

Articles from other publishers (4)

Kensuke Moriwaki. 2022. Osteoporotic Fracture and Systemic Skeletal Disorders. Osteoporotic Fracture and Systemic Skeletal Disorders 473 480 .
Md Azharuddin, Mohammad Adil, Rashid Ali Khan, Pinaki Ghosh, Prem Kapur & Manju Sharma. (2020) Systematic evidence of health economic evaluation of drugs for postmenopausal osteoporosis: A quality appraisal. Osteoporosis and Sarcopenia 6:2, pages 39-52.
Crossref
Mickaël Hiligsmann, Silvia M. Evers, Wafa Ben Sedrine, John A. Kanis, Bram Ramaekers, Jean-Yves Reginster, Stuart Silverman, Caroline E. Wyers & Annelies Boonen. (2014) A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis. PharmacoEconomics 33:3, pages 205-224.
Crossref
. (2013) Bazedoxifene won't break the bank in Spain. PharmacoEconomics & Outcomes News 683:1, pages 7-7.
Crossref